Cdk2 is required for p53-independent G2/M checkpoint control

Cell cycle, CDKs and cancer: a changing paradigm

Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · see citing works

Cell-cycle checkpoints and cancer

Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · see citing works

Requirement for p53 and p21 to Sustain G ₂ Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · see citing works

An Oncogene-Induced DNA Damage Model for Cancer Development

Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · see citing works

ATR: an essential regulator of genome integrity

Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798 · see citing works

The DNA Damage Response: Ten Years After

Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705 · see citing works

Chk1 is an essential kinase that is regulated by Atr and required for the G ₂ /M DNA damage checkpoint

Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625 · see citing works

Mammalian cyclin-dependent kinases

Malumbres, M., & Barbacid, M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.09.005 · Cited by 1,294 · see citing works

p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

Waldman, T. A., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 1,203 · see citing works

Cdk1 is sufficient to drive the mammalian cell cycle

Santamarı́a, D., Barrière, C., Cerqueira, A., Hunt, S. L., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P. R., Malumbres, M., & Barbacid, M. (2007) · Nature · doi:10.1038/nature06046 · Cited by 1,096 · see citing works

ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091 · see citing works

Living with or without cyclins and cyclin-dependent kinases

Sherr, C. J., & Roberts, J. M. (2004) · Genes & Development · doi:10.1101/gad.1256504 · Cited by 1,089 · see citing works

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085 · see citing works

ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks

Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G. C. M., Lukas, J., & Jackson, S. P. (2006) · Nature Cell Biology · doi:10.1038/ncb1337 · Cited by 1,064 · see citing works

ATR and ATRIP: Partners in Checkpoint Signaling

Cortez, D., Guntuku, S., Qin, J., & Elledge, S. J. (2001) · Science · doi:10.1126/science.1065521 · Cited by 985 · see citing works

14-3-3σ is required to prevent mitotic catastrophe after DNA damage

Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895 · see citing works

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 830 · see citing works

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice

Ortega, S., Priéto, I., Odajima, J., Martín, A. L., Dubus, P. R., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 798 · see citing works

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793 · see citing works

Rapid Destruction of Human Cdc25A in Response to DNA Damage

Mailand, N., Falck, J., Lukas, C., Syljuåsen, R. G., Welcker, M., Bartek, J., & Lukas, J. (2000) · Science · doi:10.1126/science.288.5470.1425 · Cited by 787 · see citing works

Cdk2 Knockout Mice Are Viable

Berthet, C., Aleem, E. A., Coppola, V., Tessarollo, L., & Kaldis, P. (2003) · Current Biology · doi:10.1016/j.cub.2003.09.024 · Cited by 665 · see citing works

Cyclin-dependent kinases and cell-cycle transitions: does one fit all?

Hochegger, H., Takeda, S., & Hunt, T. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2510 · Cited by 599 · see citing works

Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A

Sørensen, C. S., Syljuåsen, R. G., Falck, J., Schroeder, T., Rönnstrand, L., Khanna, K. K., Zhou, B.-B., Bártek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00048-5 · Cited by 559 · see citing works

Proliferation of cancer cells despite CDK2 inhibition

Tetsu, O., & McCormick, F. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 467 · see citing works

Regulating mammalian checkpoints through Cdc25 inactivation

Donzelli, M., & Draetta, G. F. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor887 · Cited by 435 · see citing works

The DNA damage-dependent intra–S phase checkpoint is regulated by parallel pathways

Falck, J., Petrini, J. H. J., Williams, B. R., Lukas, J., & Bartek, J. (2002) · Nature Genetics · doi:10.1038/ng845 · Cited by 392 · see citing works

Four-dimensional control of the cell cycle

Pines, J. (1999) · Nature Cell Biology · doi:10.1038/11041 · Cited by 389 · see citing works

Polo-like Kinase-1 Controls Recovery from a G2 DNA Damage-Induced Arrest in Mammalian Cells

van Vugt, M. A. T. M., Bras, A. L., & Medema, R. H. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.015 · Cited by 386 · see citing works

Cdc2–cyclin E complexes regulate the G1/S phase transition

Aleem, E. A., Kiyokawa, H., & Kaldis, P. (2005) · Nature Cell Biology · doi:10.1038/ncb1284 · Cited by 383 · see citing works

CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis.

Mailand, N., & Diffley, J. (2005) · Cell · doi:10.1016/j.cell.2005.08.013 · Cited by 373 · see citing works

CDC6: from DNA replication to cell cycle checkpoints and oncogenesis

Borlado, L. R., & Méndez, J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm268 · Cited by 264 · see citing works

Loss of Geminin induces rereplication in the presence of functional p53

Melixetian, M. B., Ballabeni, A., Masiero, L., Gasparini, P., Zamponi, R., Bártek, J., Lukas, J., & Helin, K. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403106 · Cited by 263 · see citing works

Human Cyclin a Is Required for Mitosis until Mid Prophase

Furuno, N., den Elzen, N. R., & Pines, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.295 · Cited by 254 · see citing works

Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1

Martín, A. L., Odajima, J., Hunt, S. L., Dubus, P. R., Ortega, S., Malumbres, M., & Barbacid, M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.006 · Cited by 223 · see citing works

Nuclear Import of Cdk/Cyclin Complexes: Identification of Distinct Mechanisms for Import of Cdk2/Cyclin E and Cdc2/Cyclin B1

Moore, J. D., Yang, J., Truant, R., & Kornbluth, S. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.2.213 · Cited by 219 · see citing works

Rapid PIKK-Dependent Release of Chk1 from Chromatin Promotes the DNA-Damage Checkpoint Response

Smits, V. A. J., Reaper, P. M., & Jackson, S. P. (2005) · Current Biology · doi:10.1016/j.cub.2005.11.066 · Cited by 199 · see citing works

p21 Inhibits Cdk1 in the Absence of Cdk2 to Maintain the G1/S Phase DNA Damage Checkpoint

Ande, S., Hilton, M. B., & Kaldis, P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0525 · Cited by 166 · see citing works

Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events

de Boer, L., Oakes, V., Beamish, H., Giles, N., Stevens, F., Somodevilla-Torres, M. J., DeSouza, C. P. C., & Gabrielli, B. G. (2008) · Oncogene · doi:10.1038/onc.2008.74 · Cited by 161 · see citing works

Combined Loss of Cdk2 and Cdk4 Results in Embryonic Lethality and Rb Hypophosphorylation

Berthet, C., Klarmann, K. D., Hilton, M. B., Suh, H. C., Keller, J. R., Kiyokawa, H., & Kaldis, P. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.004 · Cited by 152 · see citing works

Cyclin A2 Regulates Nuclear-Envelope Breakdown and the Nuclear Accumulation of Cyclin B1

Gong, D., Pomerening, J. R., Myers, J. W., Gustavsson, C., Jones, J. T., Hahn, A. T., Meyer, T., & Ferrell, J. E. (2007) · Current Biology · doi:10.1016/j.cub.2006.11.066 · Cited by 151 · see citing works

The role of Cdc6 in ensuring complete genome licensing and S phase checkpoint activation

Oehlmann, M., Score, A. J., & Blow, J. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200311044 · Cited by 135 · see citing works

Genetic knockouts and knockins in human somatic cells

Rago, C., Vogelstein, B., & Bunz, F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.408 · Cited by 120 · see citing works

All aboard the cyclin train: subcellular trafficking of cyclins and their CDK partners

Yang, J., & Kornbluth, S. A. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01577-9 · Cited by 119 · see citing works

Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells.

Feng, D., Tu, Z., Wu, W., & Liang, C. (2003) · PubMed · Cited by 112 · see citing works

Specialized Roles of the Two Mitotic Cyclins in Somatic Cells: Cyclin A as an Activator of M Phase–promoting Factor

Fung, T. K., Ma, H. T., & Poon, R. Y. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1092 · Cited by 110 · see citing works

Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells

Mitra, J., & Enders, G. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207446 · Cited by 106 · see citing works

Human replication protein Cdc6 prevents mitosis through a checkpoint mechanism that implicates Chk1

Clay-Farrace, L., Pelizon, C., Santamarı́a, D., Pines, J., & Laskey, R. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg046 · Cited by 99 · see citing works

The functional role of Cdc6 in S–G2/M in mammalian cells

Lau, E. K., Zhu, C., Abraham, R. T., & Jiang, W. B. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400624 · Cited by 89 · see citing works

Cell-specific responses to loss of cyclin-dependent kinases

Berthet, C., & Kaldis, P. (2007) · Oncogene · doi:10.1038/sj.onc.1210243 · Cited by 88 · see citing works

Improved methods for the generation of human gene knockout and knockin cell lines

Topaloglu, Ö. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni160 · Cited by 77 · see citing works

Origin licensing and p53 status regulate Cdk2 activity during G1

Nevis, K. R., Cordeiro‐Stone, M., & Cook, J. G. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8811 · Cited by 73 · see citing works

Cyclin-Dependent Kinase 2–Dependent Phosphorylation of ATRIP Regulates the G2-M Checkpoint Response to DNA Damage

Myers, J. S., Zhao, R., Xu, X., Ham, A. L., & Cortez, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0495 · Cited by 66 · see citing works

Functional genomic screens identify CINP as a genome maintenance protein

Lovejoy, C. A., Xu, X., Bansbach, C. E., Glick, G. G., Zhao, R., Ye, F., Sirbu, B. M., Titus, L. C., Shyr, Y., & Cortez, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909345106 · Cited by 64 · see citing works

Unmasking the Redundancy Between Cdk1 and Cdk2 at G2 Phase in Human Cancer Cell Lines

L’Italien, L., Tanudji, M., Russell, L., & Schebye, X. M. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2721 · Cited by 63 · see citing works

Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation

Hurley, P. J., Wilsker, D. F., & Bunz, F. (2006) · Oncogene · doi:10.1038/sj.onc.1210049 · Cited by 57 · see citing works

CDC6 interaction with ATR regulates activation of a replication checkpoint in higher eukaryotic cells

Yoshida, K., Sugimoto, N., Iwahori, S., Yugawa, T., Narisawa‐Saito, M., Kiyono, T., & Fujita, M. (2010) · Journal of Cell Science · doi:10.1242/jcs.058693 · Cited by 47 · see citing works

Cdc18 Enforces Long-Term Maintenance of the S Phase Checkpoint by Anchoring the Rad3-Rad26 Complex to Chromatin

Hermand, D., & Nurse, P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.014 · Cited by 36 · see citing works

ATP-dependent activation of p21 WAF1/CIP1 -associated Cdk2 by Cdc6

Kan, Q., Jinno, S., Yamamoto, H., Kobayashi, K., & Okayama, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706392105 · Cited by 22 · see citing works

Divergent S Phase Checkpoint Activation Arising from Prereplicative Complex Deficiency Controls Cell Survival

Lau, E. K., Chiang, G. G., Abraham, R. T., & Jiang, W. B. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0022 · Cited by 20 · see citing works

Cdc6 Determines Utilization of p21WAF1/CIP1-dependent Damage Checkpoint in S Phase Cells

Kan, Q., Jinno, S., Kobayashi, K., Yamamoto, H., & Okayama, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802055200 · Cited by 19 · see citing works

ATR (AT mutated Rad3 related) activity stabilizes Cdc6 and delays G2/M-phase entry during hydroxyurea-induced S-phase arrest of HeLa cells

Liu, L., Choi, J. H., Yim, H., Choi, J. S., Park, B. D., Cho, S. J., & Lee, S. K. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.12.014 · Cited by 19 · see citing works

Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB

Tripathi, V., Shen, Z., Chakraborty, A., Giri, S., Freier, S. M., Wu, X., Zhang, Y., Gorospe, M., Prasanth, S. G., Lal, A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003368 · Cited by 753 · see citing works

Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories

Ge, X. Q., & Blow, J. J. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201007074 · Cited by 219 · see citing works

Physiological Relevance of Cell Cycle Kinases

Malumbres, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00025.2010 · Cited by 215 · see citing works

Spatial competition constrains resistance to targeted cancer therapy

Bačević, K., Noble, R., Soffar, A. A., Ammar, O., Boszonyik, B., Prieto, S., Vincent, C., Hochberg, M., Krasińska, L., & Fisher, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01516-1 · Cited by 121 · see citing works

The CDK Network: Linking Cycles of Cell Division and Gene Expression

Fisher, R. P. (2012) · Genes & Cancer · doi:10.1177/1947601912473308 · Cited by 114 · see citing works

NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites

Ray, A., Milum, K., Battu, A., Wani, G., & Wani, A. A. (2013) · DNA Repair · doi:10.1016/j.dnarep.2013.01.003 · Cited by 85 · see citing works

Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage

Bačević, K., Lossaint, G., Achour, T. N., Georget, V., Fisher, D., & Dulić, V. (2017) · Scientific Reports · doi:10.1038/s41598-017-12868-5 · Cited by 84 · see citing works

Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer

Brill, E., Yokoyama, T., Nair, J. R., Yu, M., Ahn, Y.-R., & Lee, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22195 · Cited by 80 · see citing works

A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway

Lin, F., Zhang, G., Yang, X., Wang, M., Wang, R., Wan, M., Wang, J., Wu, B. M., Yan, T., & Jia, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115933 · Cited by 71 · see citing works

Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors

El‐Naggar, A. M., El-Hashash, M. A. A., & Elkaeed, E. B. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104615 · Cited by 68 · see citing works

ATR mediates cisplatin resistance in a p53 genotype-specific manner

Sangster‐Guity, N., Conrad, B., Papadopoulos, N., & Bunz, F. (2011) · Oncogene · doi:10.1038/onc.2010.624 · Cited by 65 · see citing works

To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response

Liu, Q., Gao, J., Zhao, C., Guo, Y., Wang, S., Shen, F., Xing, X., & Luo, Y. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102702 · Cited by 63 · see citing works

Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors

Hassan, G. S., Georgey, H. H., Mohammed, E. Z., George, R. F., Mahmoud, W. R., & Omar, F. A. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113389 · Cited by 62 · see citing works

Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human Cells

Wohlbold, L., Merrick, K. A., De, S., Amat, R., Kim, J. H., Larochelle, S., Allen, J. J., Zhang, C., Shokat, K. M., Petrini, J. H. J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002935 · Cited by 60 · see citing works

Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr

Lapek, J. D., Lewinski, M. K., Wozniak, J. M., Guatelli, J., & Gonzalez, D. J. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.066019 · Cited by 61 · see citing works

miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2

Nian, W., Xu-jun, A., Wu, Y., Huang, Y., Shao, J., Wang, Y., Chen, Z., CHEN, F., & Wang, D. (2013) · Oncology Letters · doi:10.3892/ol.2013.1375 · Cited by 59 · see citing works

A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild-Type, Advanced Triple-Negative Breast Cancer

Gatti-Mays, M. E., Karzai, F. H., Soltani, S. N., Zimmer, A. S., Green, J. E., Lee, M.-J., Trepel, J. B., Yuno, A., Lipkowitz, S., Nair, J. R., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0491 · Cited by 58 · see citing works

Molecular chemotherapeutic potential of butein: A concise review

Jayasooriya, R. G. P. T., Molagoda, I. M. N., Park, C., Jeong, J.-W., Choi, Y. H., Moon, D., Kim, M.-O., & Kim, G. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.12.028 · Cited by 57 · see citing works

The other side of the coin: The tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND–CDK4/6–RB axis

Lou, X., Zhang, J., Liu, S., Lou, X., & Liao, D. J. (2014) · Cell Cycle · doi:10.4161/cc.29082 · Cited by 49 · see citing works

A Comparative Analysis of Constitutive Promoters Located in Adeno-Associated Viral Vectors

Damdindorj, L., Karnan, S., Ota, A., Hossain, E., Konishi, Y., Hosokawa, Y., & Konishi, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106472 · Cited by 45 · see citing works

miR-483 is Down-Regulated in Polycystic Ovarian Syndrome and Inhibits KGN Cell Proliferation via Targeting Insulin-Like Growth Factor 1 (IGF1)

Xiang, Y., Song, Y., Li, Y., Zhao, D., Ma, L., & Tan, L. (2016) · Medical Science Monitor · doi:10.12659/msm.897301 · Cited by 46 · see citing works

Activation of Checkpoint Kinase 2 by 3,3′-Diindolylmethane Is Required for Causing G2/M Cell Cycle Arrest in Human Ovarian Cancer Cells

Kandala, P. K., & Srivastava, S. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.063750 · Cited by 45 · see citing works

An Integrated Chemical Biology Approach Provides Insight into Cdk2 Functional Redundancy and Inhibitor Sensitivity

Echalier, A., Cot, E., Camasses, A., Hodimont, E., Hoh, F., Jay, P., Sheinerman, F. B., Krasińska, L., & Fisher, D. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.06.015 · Cited by 44 · see citing works

CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability

Dozier, C., Mazzolini, L., Cénac, C., Froment, C., Burlet‐Schiltz, O., Besson, A., & Manenti, S. (2017) · Oncogene · doi:10.1038/onc.2016.506 · Cited by 43 · see citing works

Physalin B induces cell cycle arrest and triggers apoptosis in breast cancer cells through modulating p53-dependent apoptotic pathway

Wang, A., Wang, S., Zhou, F., Li, P., Wang, Y., Gan, L., & Lin, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.094 · Cited by 42 · see citing works

Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

Robb, C. M., Kour, S., Contreras, J. I., Agarwal, E., Barger, C. J., Rana, S., Sonawane, Y. A., Neilsen, B. K., Taylor, M., Kizhake, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23749 · Cited by 41 · see citing works

Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis

Li, T., Gu, M., Deng, A., & Qian, C. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01309-5 · Cited by 41 · see citing works

In vitro cytotoxicity of SiO2 or ZnO nanoparticles with different sizes and surface charges on U373MG human glioblastoma cells

An, S. S. A., Kim, J.-E., Kim, H., Meang, E.-H., Song, Y., & Kim, M.-K. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s57936 · Cited by 40 · see citing works

The p53–p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function

Lo, P., Lee, J. S., & Sukumar, S. V. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.09.017 · Cited by 36 · see citing works

Promotion of HepG2 cell apoptosis by flower of Allium atroviolaceum and the mechanism of action

Khazaei, S., Hamid, R. A., Esa, N., Ramachandran, V., Aalam, F., Etemad, A., & Ismail, P. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1594-6 · Cited by 36 · see citing works

Synthesis, in vitro anticancer activity and in silico studies of certain pyrazole-based derivatives as potential inhibitors of cyclin dependent kinases (CDKs)

Mohammed, E. Z., Mahmoud, W. R., George, R. F., Hassan, G. S., Omar, F. A., & Georgey, H. H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105347 · Cited by 35 · see citing works

Three independent mechanisms for arrest in G2after ionizing radiation

Landsverk, K. S., Patzke, S., Rein, I. D., Stokke, C., Lyng, H., Angelis, P. M. D., & Stokke, T. (2011) · Cell Cycle · doi:10.4161/cc.10.5.14968 · Cited by 33 · see citing works

Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice

Spetz, J. K. E., Langen, B., Rudqvist, N.-P., Parris, T. Z., Helou, K., Nilsson, O., & Forssell-Aronsson, E. B. (2017) · BMC Cancer · doi:10.1186/s12885-017-3524-x · Cited by 32 · see citing works

NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma

Neri, L., Lasa, M., Elósegui-Artola, A., D’Avola, D., Carte, B., Gázquez, C., Alve, S., Roca‐Cusachs, P., Iñarrairaegui, M., Herrero, J. I., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17332 · Cited by 31 · see citing works

Interplay Between the Cell Cycle and Double-Strand Break Response in Mammalian Cells

Beishline, K., & Azizkhan‐Clifford, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_3 · Cited by 29 · see citing works

Discovery of AXL Degraders with Improved Potencies in Triple-Negative Breast Cancer (TNBC) Cells

He, R. R., Song, Z., Bai, Y., He, S., Huang, J., Wang, Y., Zhou, F., Huang, W., Guo, J., Wang, Z., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01682 · Cited by 28 · see citing works

Phosphorylation of CDC25A on SER283 in late S/G2 by CDK/cyclin complexes accelerates mitotic entry

Mazzolini, L., Broban, A., Froment, C., Burlet‐Schiltz, O., Besson, A., Manenti, S., & Dozier, C. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1220455 · Cited by 27 · see citing works

Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeutics

Hussmann, M., Janke, K., Kranz, P., Neumann, F., Mersch, E., Baumann, M., Göpelt, K., Brockmeier, U., & Metzen, E. (2015) · Oncotarget · doi:10.18632/oncotarget.5746 · Cited by 27 · see citing works

Novel pyrazolopyrimidines: Synthesis, in vitro cytotoxic activity and mechanistic investigation

Hassan, G. S., Rahman, D. E. A., Nissan, Y. M., Abdelmajeed, E. A., & Abdelghany, T. M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.003 · Cited by 24 · see citing works

The human HECA interacts with cyclins and CDKs to antagonize Wnt-mediated proliferation and chemoresistance of head and neck cancer cells

Dowejko, A., Bauer, R. J., Bauer, K., Müller-Richter, U. D. A., & Reichert, T. E. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.11.004 · Cited by 23 · see citing works

Cyclin-dependent kinases regulate apoptosis of intestinal epithelial cells

Bhattacharya, S., Ray, R. M., & Johnson, L. R. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0942-3 · Cited by 22 · see citing works

The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment

Stoll, E. A., Horner, P. J., & Rostomily, R. (2013) · Aging Cell · doi:10.1111/acel.12104 · Cited by 22 · see citing works

A deep learning model based on sparse auto-encoder for prioritizing cancer-related genes and drug target combinations

Chang, J.-W., Ding, Y., Qamar, M. T. U., Shen, Y., Gao, J., & Chen, L. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz044 · Cited by 22 · see citing works

Bisacylimidoselenocarbamates Cause G2/M Arrest Associated with the Modulation of CDK1 and Chk2 in Human Breast Cancer MCF-7 Cells

Lamberto, I., Plano, D., Moreno, E., Font, M., Palop, J. A., Sanmartín, C., & Encı́o, I. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320120010 · Cited by 21 · see citing works

Overexpression of DOC-1R Inhibits Cell Cycle G1/S Transition by Repressing CDK2 Expression and Activation

Liu, Q., Liu, X., Gao, J., Shi, X., Hu, X., Wang, S., & Luo, Y. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.5763 · Cited by 21 · see citing works

A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment

Huang, C., Yang, S.-H., Huang, S.-M., Lin, C.-M., Chien, C., Chen, Y., Lee, C., Wu, H.-H., & Chang, C. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-82 · Cited by 20 · see citing works

MAEL gene contributes to bovine testicular development through the m5C-mediated splicing

Liu, S., Ma, X., Wang, Z., Lin, F., Li, M., Li, Y., Yang, L., Rushdi, H. E., Riaz, H., Gao, T., et al. (2023) · iScience · doi:10.1016/j.isci.2023.105941 · Cited by 16 · see citing works

Identification of microRNAs involved in growth arrest and cell death in hydrogen peroxide-treated human dermal papilla cells

KIM, O.-Y., Cha, H. J., Ahn, K. J., An, I., An, S., & Bae, S. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2158 · Cited by 16 · see citing works

N-Hydroxycinnamide Derivatives of Osthole Presenting Genotoxicity and Cytotoxicity against Human Colon Adenocarcinoma Cells in Vitro and in Vivo

Liu, L.-Y., Huang, W., Lin, R.-J., Lin, S.-Y., & Liang, Y. (2013) · Chemical Research in Toxicology · doi:10.1021/tx400271n · Cited by 16 · see citing works

Simple Monitoring of Gene Targeting Efficiency in Human Somatic Cell Lines Using the PIGA Gene

Karnan, S., Konishi, Y., Ota, A., Takahashi, M., Damdindorj, L., Hosokawa, Y., & Konishi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047389 · Cited by 16 · see citing works

Design, synthesis, and biological evaluation of furan‐bearing pyrazolo[3,4‐b]pyridines as novel inhibitors of CDK2 and P53–MDM2 protein–protein interaction

Ezzat, M. A. F., Elmasry, G. F., El‐Mageed, M. M. A. A., Fouad, M. A., Abdel‐Aziz, H. A., & Elewa, S. I. (2023) · Drug Development Research · doi:10.1002/ddr.22079 · Cited by 15 · see citing works

GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner

Rivas, V., González-Muñoz, T., Albitre, Á., Lafarga, V., Delgado‐Arévalo, C., Mayor, F., & Penela, P. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02143-8 · Cited by 15 · see citing works

Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells

Wilsker, D. F., Chung, J., & Bunz, F. (2012) · Cell Cycle · doi:10.4161/cc.19944 · Cited by 14 · see citing works

MicroRNA-200b Regulates the Proliferation and Differentiation of Ovine Preadipocytes by Targeting p27 and KLF9

Jin, X., Wang, J., Hu, J., Liu, X., Li, S., Lu, Y., Zhen, H., Li, M., Zhao, Z., & Luo, Y. (2021) · Animals · doi:10.3390/ani11082417 · Cited by 14 · see citing works

Wip1 contributes to cell homeostasis maintained by the steady-state level of Wtp53

Park, H. K., Panneerselvam, J., Dudimah, F. D., Dong, G.-Z., Sebastian, S., Zhang, J., & Fei, P. (2011) · Cell Cycle · doi:10.4161/cc.10.15.15923 · Cited by 14 · see citing works

Coupling function of cyclin‐dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma

Xu, C., Zhang, W., Zhang, X., Zhou, D., Qu, L., Liu, J., Xiao, M., Ni, R., Jiang, F., Ni, W., et al. (2018) · Cancer Science · doi:10.1111/cas.13882 · Cited by 14 · see citing works

γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells

Kim, S., Hinoue, T., Kim, M. S., Sohn, K., Cho, R. C., Cole, P. D., Weisenberger, D. J., Laird, P. W., & Kim, Y. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0444-0 · Cited by 14 · see citing works

New Insights into Cell Cycle Regulation and DNA Damage Response in Embryonic Stem Cells

Suvorova, I. I., Katolikova, N. V., & Pospelov, V. A. (2012) · International review of cytology · doi:10.1016/b978-0-12-394310-1.00004-7 · Cited by 13 · see citing works

Aberrant activation of cyclin A-CDK induces G2/M-phase checkpoint in human cells

Akaike, Y., & Chibazakura, T. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1693119 · Cited by 13 · see citing works

Non‐Cell Cycle Functions of the CDK Network in Ciliogenesis: Recycling the Cell Cycle Oscillator

Krasińska, L., & Fisher, D. (2018) · BioEssays · doi:10.1002/bies.201800016 · Cited by 12 · see citing works

Effect of methionine deficiency on the apoptosis and cell cycle of kidney in broilers

Song, B., Zeng, Q., Liu, Y., & Wu, B. (2019) · Research in Veterinary Science · doi:10.1016/j.rvsc.2019.09.013 · Cited by 12 · see citing works

Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer

Evangelisti, G., Barra, F., Moioli, M., Sala, P., Stigliani, S., Gustavino, C., Costantini, S., & Ferrero, S. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1783238 · Cited by 12 · see citing works

Cyclin Dependent Kinase as Significant Target for Cancer Treatment

Singh, S. K., Tripathi, S. K., Dessalew, N., & Singh, P. C. (2012) · Current Cancer Therapy Reviews · doi:10.2174/157339412802653164 · Cited by 11 · see citing works

Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition

Maher, M., Kassab, A. E., Zaher, A. F., & Mahmoud, Z. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666190417153350 · Cited by 11 · see citing works

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells

Zhang, L., Ye, B., Lin, Y., Li, Y.-D., Wang, J., Chen, Z., Ping, F., & Chen, Z.-S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.867128 · Cited by 11 · see citing works

CDK2 knockdown enhances head and neck cancer cell radiosensitivity

Soffar, A. A., Storch, K., Aleem, E. A., & Cordes, N. (2013) · International Journal of Radiation Biology · doi:10.3109/09553002.2013.782108 · Cited by 11 · see citing works

Targeted Mutations in the ATR Pathway Define Agent-Specific Requirements for Cancer Cell Growth and Survival

Wilsker, D. F., Chung, J., Pradilla, I. F., Petermann, E., Helleday, T., & Bunz, F. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0675 · Cited by 10 · see citing works

Tumor tissue protein signatures reflect histological grade of breast cancer

Skoog, P., Ohlsson, M., Fernö, M., Rydén, L., Borrebaeck, C. A. K., & Wingren, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179775 · Cited by 10 · see citing works

Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma

Cheng, X., Li, D., Qi, T., Sun, J., Zhou, T., & Zheng, W. (2022) · Scientific Reports · doi:10.1038/s41598-021-04055-4 · Cited by 9 · see citing works

CtIP promotes G2/M arrest in etoposide‐treated HCT116 cells in a p53‐independent manner

Chen, H., Shan, J., Chen, D., Wang, R., Qi, W., Wang, H., Ke, Y., Liu, W., & Zeng, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27824 · Cited by 9 · see citing works

New pyrrolidine‐carboxamide derivatives as dual antiproliferative EGFR / CDK2 inhibitors

Frejat, F. O. A., Zhao, B., Furaijit, N., Wang, L., Abou‐Zied, H. A., Fathy, H. M., Mohamed, F. A., Youssif, B. G. M., & Wu, C. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14422 · Cited by 7 · see citing works

Development of 9H-purine scaffold as novel CDK2 inhibitors: Design, synthesis, and biological evaluation

Zhang, Y., Liu, X., Li, Z., Wang, X., & Tang, C. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130166 · Cited by 6 · see citing works

Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells

Oikonomidi, I., Kameswaran, V., Pham, V. C., Zuazo-Gaztelu, I., Gutgesell, L. M., Marsters, S. A., Dániel, B., Lill, J. R., Modrusan, Z. D., & Ashkenazi, A. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003096 · Cited by 6 · see citing works

DNA damage responses in murine Pre-B cells with genetic deficiencies in damage response genes

Innes, C. L., Hesse, J. E., Morales, A. J., Helmink, B. A., Schurman, S. H., Sleckman, B. P., & Paules, R. S. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1693118 · Cited by 6 · see citing works

Paris saponin VII restrains PD-L1 mediated immune evasion through the AKT1 and STAT3 signaling pathways

Wang, Y., Li, Y., Zhang, Y., Li, Y., Zhao, L., Tong, L., Zhu, X. M., Wang, J., & Dong, Y. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111562 · Cited by 5 · see citing works

A System for the Measurement of Gene Targeting Efficiency in Human Cell Lines Using an Antibiotic Resistance—GFP Fusion Gene

Konishi, Y., Karnan, S., Takahashi, M., Ota, A., Damdindorj, L., Hosokawa, Y., & Konishi, H. (2012) · BioTechniques · doi:10.2144/0000113911 · Cited by 5 · see citing works

Limited Repair of Critical DNA Damage in Cells Exposed to Low Dose Radiation

Gaziev, A. I., & Shaikhaev, G. (2012) · InTech eBooks · doi:10.5772/33611 · Cited by 5 · see citing works

Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities

Li, E., Ho, R., Tao, R., Choi, Y. W. Y., Shin, C. Y., Chen, S. Y., Gokbayrak, B., Senz, J., Yao, B., Johnston, L., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01053-x · Cited by 3 · see citing works

Activation of death receptor, DR5 and mitochondria-mediated apoptosis by a 3,4,5-trimethoxybenzyloxy derivative in wild-type and p53 mutant colorectal cancer cell lines

Chan, Z. C. K., Leong, K. H., Kareem, H. S., Norazit, A., Noor, S. M., & Ariffin, A. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01730-2 · Cited by 3 · see citing works

Synthesis and in vitro anticancer activity of some 2-oxindoline derivatives as potential CDK2 inhibitors

Alshaye, N. A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2187222 · Cited by 3 · see citing works

Dynamic molecular responses of the sea urchin Strongylocentrotus intermedius to pathogen infection: Insights from a serial comparative transcriptome analysis

Sun, J., Liu, J., Xue, M., Zhao, T., Song, J., Zhang, W., Chang, Y., & Zhan, Y. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110176 · Cited by 3 · see citing works

Adverse Cerebral Cardiovascular Events Associated With Checkpoint Kinase 1 Inhibitors: A Systemic Review

Yang, T., Gu, J., Du, C., Shan, T., Wei, T., Li, Y., & Wang, L. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000997 · Cited by 3 · see citing works

Deficiency of ATF2 retards senescence induced by replication stress and pamidronate in mouse jaw bone marrow stem cells

Li, Y., Lin, Y., Chen, Z., Ji, W., & Liu, H. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111579 · Cited by 2 · see citing works

Screening on human hepatoma cell line HepG-2 nucleus and cytoplasm protein after CDK2 silencing by RNAi

Han, X., Wang, Z., Wang, W., Bai, R., Zhao, P., & Shang, J. (2014) · Cytotechnology · doi:10.1007/s10616-013-9604-0 · Cited by 2 · see citing works

Etoposide radiosensitizes p53-defective cholangiocarcinoma cell lines independent of their G2 checkpoint efficacies

Hematulin, A., Meethang, S., Utapom, K., Wongkham, S., & Sagan, D. (2018) · Oncology Letters · doi:10.3892/ol.2018.7754 · Cited by 2 · see citing works

A general, robust framework for determining the key species that forewarns sudden transitions in biological circuits

Kashyap, D., Kaur, T., Dutta, P. S., & Sinha, S. K. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d4cp04863f · Cited by 1 · see citing works

Microenvironmental signals combine to induce non-additive molecular and phenotypic responses in mammary epithelial cells

Mclean, I. C., Gross, S. M., Copperman, J., Derrick, D. S., Paul, I., Emili, A., & Heiser, L. M. (2025) · iScience · doi:10.1016/j.isci.2025.113407 · Cited by 1 · see citing works

Discovery of Potent CDK2 Inhibitors Through Structure‐Based Virtual Screening and MD Simulation Studies

Patel, D. A., Prajapati, A. S., Patel, S. S., Dabhi, R. C., Kotadiya, D. D., & Patel, H. D. (2026) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.70202 · Cited by 1 · see citing works

Candidate oncogene placenta specific 8 affect cell growth and cell migration in non- small cell lung cancersPreprint

Zhou, M.-L., Ma, J.-N., Xu, X., Gao, X.-Y., Wang, H.-X., Shen, J., & Xue, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2533161/v1 · Cited by 1 · see citing works

Regulação do ciclo celular após inibição farmacológica da enzima ácido graxo sintase em linhagem derivada de melanoma murino, B16-F10

Ortega, R. M. (2010) · doi:10.47749/t/unicamp.2010.775509

Cyclin A/CDK2 regulates multiple G2 phase pathways

Oakes, V. (2012)

Overexpression of DOC-1R Inhibits Cell Cycle G1/S Transition by Repressing CDK2 Expression and

Liu, Q., Liu, X., Gao, J., Shi, X., Hu, X., Wang, S., & Luo, Y. (2013)

TYPES OF DNA DAMAGE

(2013) · CRC Press eBooks · doi:10.1201/b14587-17

Computational studies on RNA processing in higher eukaryotes

Brüggemann, M. (2021) · doi:10.21248/gups.61384

Candidate oncogene placenta specific 8 affects cell growth and cell migration in non-small cell lung cancers

MA, J., ZHOU, M., Xu, X., GAO, X., WANG, H., SHEN, J., & Xue, L. (2024) · Biocell · doi:10.32604/biocell.2023.045076

IRF4 mediates non-enzymatic dependency on IRE1 in Multiple Myeloma cellsPreprint

Oikonomidi, I., Kameswaran, V., Pham, V. C., Zuazo-Gaztelu, I., Gutgesell, L. M., Marsters, S. A., Dániel, B., Lill, J. R., Modrusan, Z. D., & Ashkenazi, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4494530/v1

Integrative Proteomics and Metabolomics Approach to Elucidate the Cardiotoxicity of Decabromodiphenyl Ethane in Zebrafish LarvaePreprint

Zhang, R., Zhang, Y., Xue, J., Zhang, R., Xie, J., Luo, X., Yang, X., Wang, H., Liu, J., Wei, J., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5116771

Integrative Analysis of EGF, OSM, and TGFB Signaling Pathways Reveals Synergistic Mechanisms Driving Cell Motility Through CXCR2 Chemotactic Signaling and CREB ActivationPreprint

Mclean, I. C., Gross, S. M., Copperman, J., Derrick, D. S., & Heiser, L. M. (2025) · bioRxiv · doi:10.1101/2025.04.03.647095

Additional file 2 of Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis

Li, T., Gu, M., 邓安梅, & Qian, C. (2020) · Figshare · doi:10.6084/m9.figshare.12486737

Additional file 1 of Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis

Li, T., Gu, M., Deng, A., & Qian, C. (2020) · Figshare · doi:10.6084/m9.figshare.12486725

Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage

Bačević, K., Lossaint, G., Achour, T. N., Georget, V., Fisher, D., & Dulić, V. (2017) · Scientific Reports · doi:10.1038/s41598-017-12868-5 · Cited by 84 · see citing works

p21 Inhibits Cdk1 in the Absence of Cdk2 to Maintain the G1/S Phase DNA Damage Checkpoint

Ande, S., Hilton, M. B., & Kaldis, P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0525 · Cited by 166 · see citing works

Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.

Park, M., Chae, H.-D., Yun, J., Jung, M., Kim, Y. S., Kim, S., Han, M. H., & Shin, D. Y. (2000) · PubMed · Cited by 105 · see citing works

Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-medicated G2-M arrest

Park, M. S., Chae, H., Yun, J. H., Jung, M. S., Kim, Y. S., Kim, S. H., Han, M. H., & Shin, D. Y. (2000) · KRIBB Repository

Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR

Goldstone, S. D., Pavey, S. J., Forrest, A. R. R., Sinnamon, J., & Gabrielli, B. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204177 · Cited by 92 · see citing works